PACS surges on investigation results and stronger 2025 guidance
PACS Group surged 53% premarket after its audit committee completed an investigation into allegations by Hindenburg Research. The probe identified financial reporting issues and led to restated statements, including a $46.1 million revenue reduction for Q2 2024. The company said probe recommendations are being implemented and raised full-year guidance, forecasting $480–$490 million in core profit.